SEARCH

SEARCH BY CITATION

References

  • 1
    Wall LL, Arrowsmith SD, Briggs ND, Browning A, Lassey A. The obstetric vesicovaginal fistula in the developing world. Obstet Gynecol Surv 2005;60:S351.
  • 2
    Browning A. The circumferential obstetric fistula: characteristics, management and outcomes. BJOG 2007;114:11726.
  • 3
    Nardos R, Browning A, Member B. Duration of bladder catheterization after surgery for obstetric fistula. Int J Gynaecol Obstet 2008;103:302.
  • 4
    Rangnekar NP, Imdad Ali N, Kaul SA, Pathak HR. Role of the Martius procedure in the management of urinary–vaginal fistulas. J Am Coll Surg 2000;191:25963.
  • 5
    Chigbu CO, Nwogu-Ikojo EE, Onah HE, Iloabachie GC. Juxtacervical vesicovaginal fistulae: outcome by route of repair. J Obstet Gynaecol 2006;26:7957.
  • 6
    Tomlinson AJ, Thornton JG. A randomised controlled trial of antibiotic prophylaxis for vesico-vaginal fistula repair. Br J Obstet Gynaecol 1998;105:3979.
  • 7
    Olusegun AK, Akinfolarin AC, Olabisi LM. A review of clinical pattern and outcome of vesicovaginal fistula. J Natl Med Assoc 2009;101:5935.
  • 8
    Browning A. Lack of value of the Martius fibrofatty graft in obstetric fistula repair. Int J Gynaecol Obstet 2006;93:337.
  • 9
    Kriplani A, Agarwal N, Parul, Gupta A, Bhatla N. Observations on aetiology and management of genital fistulas. Arch Gynecol Obstet 2005;271:148.
  • 10
    Nardos R, Browning A, Chen CC. Risk factors that predict failure after vaginal repair of obstetric vesicovaginal fistulae. Am J Obstet Gynecol 2009;200:578e14.
  • 11
    Browning A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG 2006;113:4825.
  • 12
    Safan A, Shaker H, Abdelaal A, Mourad MS, Albaz M. Fibrin glue versus Martius flap interpositioning in the repair of complicated obstetric vesicovaginal fistula. A prospective multi-institution randomized trial. Neurourol Urodyn 2009;28:43841.
  • 13
    Kirschner C, Yost K, Du H, Karshima J, Arrowsmith S, Wall L. Obstetric fistula: the ECWA Evangel VVF Center surgical experience from Jos, Nigeria. Int Urogynecol J 2010;21:152533.
  • 14
    Kapoor R, Ansari MS, Singh P, Gupta P, Khurana N, Mandhani A, et al. Management of vesicovaginal fistula: an experience of 52 cases with a rationalized algorithm for choosing the transvaginal or transabdominal approach. Indian J Urol 2007;23:3726.
  • 15
    Morhason-Bello IO, Ojengbede OA, Adedokun BO, Okunlola MA, Oladokun A. Uncomplicated midvaginal vesico-vaginal fistula repair in Ibadan: a comparison of the abdominal and vaginal routes. Ann Ibadan Postgrad Med 2008;6:3943.
  • 16
    Zambon JP, Batezini NS, Pinto ER, Skaff M, Girotti ME, Almeida FG. Do we need new surgical techniques to repair vesico-vaginal fistulas? Int Urogynecol J Pelvic Floor Dysfunct 2010;21:33742.
  • 17
    Carr LK, Webster GD. Abdominal repair of vesicovaginal fistula. Urology 1996;48:101.
  • 18
    Hancock B, Browning A. Practical Obstetric Fistula Surgery. London: Royal Society of Medicine Press, 2009.
  • 19
    Genadry RR, Creanga AA, Roenneburg ML, Wheeless CR. Complex obstetric fistulas. Int J Gynaecol Obstet 2007;99(Suppl. 1):S516.
  • 20
    Creanga AA, Genadry RR. Obstetric fistulas: a clinical review. Int J Gynaecol Obstet 2007;99(Suppl. 1):S406.
  • 21
    Hill EC. Repair of vesico-vaginal fistula. Calif Med 1962;97:2169.
  • 22
    Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol 1999;149:9813.
  • 23
    Walker AM. Confounding by indication. Epidemiology 1996;7:3356.
  • 24
    Hak E, Verheij TJM, Grobbee DE, Nichol KL, Hoes AW. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 2002;56:9515.
  • 25
    Johnson K, Peterman A. Incontinence Data from the Demographic and Health Surveys: Comparative Analysis of a Proxy Measurement of Vaginal Fistula and Recommendations for Future Population-Based Data Collection. Calverton, MD: Macro International Inc., 2008.
  • 26
    Carter RE, Zhang X, Woolson RF, Apfel CC. Statistical analysis of correlated relative risks. J Data Sci 2009;7:397407.
  • 27
    Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005;162:199200.
  • 28
    Westreich D, Cole SR. Invited commentary: positivity in practice. Am J Epidemiol 2010;171:6747. discussion 8–81.
  • 29
    Hernan MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health 2006;60:57886.
  • 30
    Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008;168:65664.
  • 31
    Manski CF. Identification Problems in the Social Sciences. Cambridge, MA: Harvard University Press, 1995.
  • 32
    Oakes JM, Messer LC, Mason S, Messer et al. Respond to ‘Positivity in Practice’. Am J Epidemiol 2010;171:6801.